Inscription Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Inscription Capital's LLY Position: Q1 2026 in Review
Inscription Capital increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $100K and bringing the position to 2,754 shares worth $2.53M. The position accounts for 0.27% of the portfolio, ranked #65.
Inscription Capital first reported a position in LLY in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.85M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Inscription Capital held 2,754 shares of Eli Lilly worth $2.53M as of Q1 2026.
- Inscription Capital bought 99 Eli Lilly shares in Q1 2026, an estimated $100K.
- Eli Lilly made up 0.27% of Inscription Capital's portfolio in Q1 2026, its #65 holding.
- Inscription Capital first reported a position in Eli Lilly in Q2 2021 and has held it in 18 quarters since.
- Inscription Capital's Eli Lilly position peaked at $2.85M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.